---
title: Legislative Counsel Packet
route: /congress/legislative
order: 20
---

# Legislative Counsel Packet

This page contains **two source documents** combined into one canonical route for staff review:

- **Legislative Counsel‚ÄìReady Redline Outline** (outline + drafting map)
- **Sample Statutory Language** (collapsible below)

## Jump to
- [Legislative Counsel‚ÄìReady Redline Outline](#legislative-counselready-redline-outline)
- [Sample Statutory Language](#sample-statutory-language)


## Legislative Counsel‚ÄìReady Redline Outline

_Source: Legislative Counsel‚ÄìReady Redline Outline_.docx_

## **Legislative Counsel‚ÄìReady Redline Outline**

(How this fits into U.S. Code and existing ACA provisions)

## **PURPOSE OF THIS DOCUMENT**

This outline shows:

- Where ACA for the People amends existing law
- What sections are added vs. modified
- How to minimize drafting friction
- Which titles can move independently
- Which provisions should be clean inserts vs. rewrites
Legislative counsel can use this as:

- a drafting map,
- a checklist,
- or a modular menu.
## **OVERALL STRUCTURE**

Bill Type:

Amendments to the Patient Protection and Affordable Care Act (PPACA) + new freestanding titles

Committees of Jurisdiction (Primary):

- House Energy & Commerce
- House Ways & Means
- Senate HELP
- Senate Finance
# **TITLE I ‚Äî FINDINGS, PURPOSES, AND DEFINITIONS (NEW)**

### **Action**

NEW TITLE added at the front of the Act

### **Reason**

- Avoids reopening ACA definitions scattered across titles
- Creates a unified interpretive lens for courts
- Anchors affordability, backbone, and enforcement intent
### **Contents**

- Congressional findings
- Statement of purpose
- Definitions for:
- ‚ÄúHealthcare Backbone‚Äù
- ‚ÄúAffordability Cap‚Äù
- ‚ÄúEssential Access Provider‚Äù
- ‚ÄúAdministrative Waste‚Äù
- ‚ÄúDelay or Denial‚Äù
# **TITLE II ‚Äî HEALTHCARE BACKBONE (NEW CORE TITLE)**

### **Action**

NEW TITLE inserted after ACA Title I (Quality, Affordable Health Care for All Americans)

### **U.S. Code Placement**

- New Part added to 42 U.S.C. ¬ß18021 et seq.
### **Key Drafting Instructions**

- Do not repeal ACA Marketplace structure
- Backbone is an additional statutory plan option
- Eligibility and benefits defined in statute
- HHS role limited to implementation mechanics
### **Sections**

- Establishment of Healthcare Backbone Plan
- Eligibility and enrollment
- Benefits floor
- Relationship to private insurance
- Federal fallback authority
# **TITLE III ‚Äî AFFORDABILITY AND COST PROTECTION**

(MODIFIES ACA ¬ß36B, ¬ß1302, ¬ß1402, ¬ß1412)

### **Action**

AMEND EXISTING ACA SECTIONS

### **Drafting Strategy**

- Replace discretionary language with formulas
- Convert affordability ‚Äústandards‚Äù into enforceable caps
- Avoid reopening unrelated subsidy mechanics
### **Key Amendments**

- Amend 26 U.S.C. ¬ß36B (premium tax credits):
- Insert statutory premium cap bands
- Eliminate cliff effects
- Amend 42 U.S.C. ¬ß18022:
- Define ‚Äútrue out-of-pocket maximum‚Äù
- Prohibit exclusions
- Add enforcement cross-references to Title IX
# **TITLE IV ‚Äî PROVIDER PAYMENT & RURAL STABILIZATION (NEW TITLE)**

### **Action**

NEW TITLE, but cross-referenced to Medicare/Medicaid authorities

### **Drafting Strategy**

- Avoid reopening Medicare fee schedules
- Use alternative payment authority
- Create new designation: ‚ÄúEssential Access Provider‚Äù
### **Sections**

- Access-based payments
- Rural hospital stabilization
- Emergency & maternity protection
- Administrative simplification for providers
# **TITLE V ‚Äî INSURANCE MARKET RULES & POWER REBALANCING**

(MODIFIES ACA Title I, Part II)

### **Action**

TARGETED AMENDMENTS to ACA insurer rules

### **Key Sections to Amend**

- 42 U.S.C. ¬ß300gg-1 et seq.
- Network adequacy standards
- Prior authorization restrictions
- Medical Loss Ratio definitions
### **Drafting Note**

- Use bright-line prohibitions, not standards
- Avoid ‚Äúreasonable‚Äù or ‚Äúappropriate‚Äù without criteria
- Explicit penalty triggers
# **TITLE VI ‚Äî ADMINISTRATIVE SIMPLIFICATION (NEW TITLE)**

### **Action**

NEW TITLE, minimal cross-code conflict

### **Drafting Strategy**

- Build on existing HHS/CMS authorities
- Standardization > new programs
- Emphasize efficiency and cost reduction
### **Sections**

- No-wrong-door enrollment
- Standardized billing
- Claims timelines
- Interoperability standards
# **TITLE VII ‚Äî PRESCRIPTION DRUG & PBM REFORM**

(MODIFIES PHSA + ERISA + Internal Revenue Code)

### **Action**

MULTI-CODE AMENDMENTS (targeted)

### **Drafting Strategy**

- Clear prohibitions (pass-through, spread pricing)
- Avoid rate-setting
- Ensure ERISA-safe federal authority
### **Sections**

- Rebate pass-through
- Spread pricing ban
- Formulary transparency
- Pharmacy protections
# **TITLE VIII ‚Äî FEDERAL‚ÄìSTATE COORDINATION & WAIVERS**

(MODIFIES ACA ¬ß1332 + Medicaid ¬ß1115 references)

### **Action**

AMEND + CONSOLIDATE WAIVER AUTHORITY

### **Drafting Strategy**

- Preserve state flexibility
- Explicit NFIB-safe language
- Federal fallback mandatory
### **Sections**

- National floor protections
- State administration option
- Unified waiver pathway
- Budget neutrality
# **TITLE IX ‚Äî OVERSIGHT, ENFORCEMENT, ACCOUNTABILITY (NEW)**

### **Action**

NEW TITLE

### **Drafting Strategy**

- Create independent Oversight Commission
- Mandatory enforcement timelines
- Public reporting
- Whistleblower protections
### **Key Feature**

- Enforcement duties written as ‚Äúshall‚Äù, not ‚Äúmay‚Äù
# **TITLE X ‚Äî DURABILITY ADDENDUM (NEW APPENDIX)**

### **Action**

NEW FINAL TITLE / APPENDIX

### **Purpose**

- Lock in enforcement
- Prevent slow-walking
- Create statutory defaults
- Enable judicial review
### **Sections**

- Nondiscretionary implementation
- Default rules for missed deadlines
- Limited private right of action
- Anti-erosion clause
- Enhanced severability
## **MODULAR PASSAGE STRATEGY (IMPORTANT FOR COUNSEL)**

These titles can move independently if needed:

- Drug reform (Title VII)
- Administrative simplification (Title VI)
- Affordability caps (Title III)
- Rural stabilization (Title IV)
The backbone (Title II) is the structural keystone but can be phased.

## **DRAFTING WARNINGS FOR COUNSEL**

‚ö†Ô∏è Avoid:

- broad ‚ÄúSecretary determines‚Äù language on major policy
- retroactive penalties
- coercive funding threats to states
‚úÖ Prefer:

- formulas
- deadlines
- defaults
- clear prohibitions
- severability everywhere
## **WHAT THIS GIVES LEGISLATIVE COUNSEL**

- A clean map of insert vs. amend
- Clear jurisdictional lanes
- Litigation-aware drafting guidance
- Modular legislative flexibility
- Reduced redrafting cycles
This is how you get from idea ‚Üí statute without losing the substance.


---

<details>
  <summary><strong>Sample Statutory Language</strong> (click to expand)</summary>

  <div style={{ marginTop: "1rem" }}>

_Source: SAMPLE STATUTORY LANGUAGE.docx_

## **ACA for the People (Model Draft)**

## **SECTION 301. STATUTORY AFFORDABILITY CAPS AND COST PROTECTIONS.**

### **(a) IN GENERAL.**

Section 36B of the Internal Revenue Code of 1986 is amended by adding at the end the following new subsection:

‚Äú(k) STATUTORY AFFORDABILITY CAPS.

(1) MAXIMUM PREMIUM CONTRIBUTION.

Notwithstanding any other provision of law, the annual premium contribution required of an applicable taxpayer for coverage under a qualified health plan or Healthcare Backbone Plan shall not exceed the applicable percentage of household income set forth in paragraph (2).

(2) APPLICABLE PERCENTAGES.

For purposes of paragraph (1), the applicable percentage shall be determined as follows:

| Household Income (% FPL) | Maximum Premium Contribution |
| --- | --- |
| ‚â§ 150% | 0.0 percent |
| >150%‚Äì200% | 2.0 percent |
| >200%‚Äì300% | 4.0 percent |
| >300%‚Äì400% | 6.0 percent |
| >400% | 8.5 percent |

(3) PROHIBITION ON COST SHIFTING.

No issuer may impose deductibles, copayments, coinsurance, or other cost-sharing mechanisms that, individually or in aggregate, have the effect of circumventing the premium contribution limits established under this subsection.

(4) TRUE OUT-OF-POCKET MAXIMUM.

For purposes of this Act, the term ‚Äòout-of-pocket maximum‚Äô shall include all cost-sharing expenditures for covered services, including prescription drugs, out-of-network emergency services, and ancillary services. No exclusions shall apply unless expressly authorized by statute.

(5) NONDISCRETIONARY ENFORCEMENT.

Compliance with this subsection shall be mandatory. The Secretary shall not waive, suspend, or modify the requirements of this subsection through regulation, guidance, or enforcement discretion.

(6) JUDICIAL REVIEW.

Failure to comply with the requirements of this subsection shall constitute final agency action subject to judicial review.‚Äù

### **(b) CONFORMING AMENDMENTS.**

Section 1302(c) of the Patient Protection and Affordable Care Act (42 U.S.C. ¬ß18022(c)) is amended to conform cost-sharing limitations to subsection (k) of section 36B of the Internal Revenue Code.

### **üîé Why this section is strong**

- Affordability is numerical, not discretionary
- Caps are enforceable without agency enthusiasm
- Courts can read and apply it directly
- Insurers cannot game around it with cost-shifting
- This survives a hostile administration and a hostile court
## **SECTION 701. PRESCRIPTION DRUG REBATE PASS-THROUGH AND SPREAD PRICING PROHIBITION.**

### **(a) REBATE PASS-THROUGH REQUIREMENT.**

Title XXVII of the Public Health Service Act (42 U.S.C. ¬ß300gg et seq.) is amended by adding at the end the following new section:

‚ÄúSEC. 2799D‚Äì1. PRESCRIPTION DRUG REBATE TRANSPARENCY AND PASS-THROUGH.

(a) IN GENERAL.

Any rebate, discount, price concession, or other remuneration received by a health plan, pharmacy benefit manager, or any affiliate thereof, in connection with a covered prescription drug, shall be applied directly to reduce the out-of-pocket cost of the covered individual at the point of sale.

(b) PROHIBITION ON RETENTION.

No entity described in subsection (a) may retain, aggregate, or reallocate such remuneration for any purpose other than reducing the cost of the drug to the covered individual.

(c) NO OFFSET OR DELAY.

The application of remuneration under this section shall not be deferred, averaged, or offset through premium adjustments or other mechanisms.

(d) ENFORCEMENT.

A violation of this section shall be treated as a prohibited transaction subject to civil monetary penalties not to exceed $100,000 per violation, adjusted annually for inflation.

(e) NONPREEMPTION OF STRONGER FEDERAL PROTECTIONS.

Nothing in this section shall be construed to limit the authority of the Secretary to impose stricter transparency or consumer protection requirements under Federal law.‚Äù

### **(b) SPREAD PRICING BAN.**

The Employee Retirement Income Security Act of 1974 is amended by inserting after section 725 the following:

‚ÄúSEC. 725A. PROHIBITION ON SPREAD PRICING.

(a) IN GENERAL.

A pharmacy benefit manager shall not charge a health plan sponsor a price for a prescription drug that exceeds the amount paid to the dispensing pharmacy for such drug, except for a bona fide administrative fee disclosed in advance.

(b) DISCLOSURE REQUIREMENT.

Any administrative fee permitted under subsection (a) shall be:

(1) flat and not percentage-based;

(2) disclosed in writing; and

(3) unrelated to the price of the drug.

(c) PROHIBITED PRACTICE.

Any differential between amounts charged and amounts paid, other than permitted fees, shall constitute unlawful spread pricing.

(d) PRIVATE ENFORCEMENT.

A plan sponsor, pharmacy, or covered individual adversely affected by a violation of this section may bring an action for injunctive relief.‚Äù

### **üîé Why this section is strong**

- No rate-setting (avoids takings claims)
- No agency creativity required
- ERISA-safe federal authority
- Mechanical compliance = easy auditing
- Patients feel savings immediately
## **What we‚Äôve now done (this is important)**

You now have:

- real statutory text
- that could be dropped into a draft bill
- with minimal reinterpretation
- and maximum durability
This is no longer ‚Äúpolicy language.‚Äù

This is law-shaped.


  </div>
</details>
